Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism
about
P1343
Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite thHuman dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cellsAn N-acetylated natural ligand of human histocompatibility leukocyte antigen (HLA)-B39. Classical major histocompatibility complex class I proteins bind peptides with a blocked NH(2) terminus in vivoNKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B moleculesImmune Checkpoint Modulators: An Emerging Antiglioma ArmamentariumNK Cell and CD4+FoxP3+ Regulatory T Cell Based Therapies for Hematopoietic Stem Cell EngraftmentCrystal structure of the human natural killer (NK) cell activating receptor NKp46 reveals structural relationship to other leukocyte receptor complex immunoreceptorsNK cells in therapy of cancerRole of CD47 in erythroid cells and in autoimmunityClonal anergy induced in a CD8+ hapten-specific cytotoxic T-cell clone by an altered hapten-peptide ligandSpecificity of HLA class I antigen recognition by human NK clones: evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type.Use of anti-HLA antibodies to mask major histocompatibility complex gene products on tumor cells can enhance susceptibility of these cells to lysis by natural killer cells.Hierarchy among multiple H-2b-restricted cytotoxic T-lymphocyte epitopes within simian virus 40 T antigen.Functional analysis of amino acid residues encompassing and surrounding two neighboring H-2Db-restricted cytotoxic T-lymphocyte epitopes in simian virus 40 tumor antigen.Molecular cloning of a macrophage-derived, interferon-inducible secreted immunoglobulin-binding protein.Major histocompatibility complex class I molecules bind natural peptide ligands lacking the amino-terminal binding residue in vivo.The Cys-67 residue of HLA-B27 influences cell surface stability, peptide specificity, and T-cell antigen presentation.High-resolution analysis of HLA class I alterations in colorectal cancer.A study of T cell tolerance to the tumor-associated antigen MDM2: cytokines can restore antigen responsiveness, but not high avidity T cell functionAllogeneic lymphocytes persist and traffic in feral MHC-matched mauritian cynomolgus macaquesModulators of arginine metabolism support cancer immunosurveillance.Human IgG1 antibodies antagonizing activating receptor NKG2D on natural killer cellsiNKT cells control mouse spontaneous carcinoma independently of tumor-specific cytotoxic T cells.Uterine Natural Killer Cells: Functional Distinctions and Influence on Pregnancy in Humans and Mice.TCR stimulation strength is inversely associated with establishment of functional brain-resident memory CD8 T cells during persistent viral infection.Human papillomavirus (HPV) type 16 E7 protein bodies cause tumour regression in miceFas ligand-mediated lysis of self bystander targets by human papillomavirus-specific CD8+ cytotoxic T lymphocytes.Cytotoxic T-lymphocyte epitope immunodominance in the control of choroid plexus tumors in simian virus 40 large T antigen transgenic mice.NK cell-based immunotherapy for malignant diseases.Heterogeneity in expression of human leukocyte antigens and melanoma-associated antigens in advanced melanoma.An endoplasmic reticulum-targeting signal sequence enhances the immunogenicity of an immunorecessive simian virus 40 large T antigen cytotoxic T-lymphocyte epitope.Multiple, non-conserved, internal viral ligands naturally presented by HLA-B27 in human respiratory syncytial virus-infected cellsThe requirement for NKG2D in NK cell-mediated rejection of parental bone marrow grafts is determined by MHC class I expressed by the graft recipient.T-cell-directed cancer vaccines: mechanisms of immune escape and immune tolerance.Recognition of tumors by the innate immune system and natural killer cells.Agonist antibody that induces human malignant cells to kill one another.NK cells, MHC class I molecules and the missing self.Damage to the blood-brain barrier during experimental cerebral malaria results from synergistic effects of CD8+ T cells with different specificitiesThe natural killer cell -- friend or foe in autoimmune disease?Interferon gamma induces lung colonization by intravenously inoculated B16 melanoma cells in parallel with enhanced expression of class I major histocompatibility complex antigens.
P2860
Q24671809-1FBB4223-5221-44B2-A3B7-E230600FBC6CQ24675226-98B5208E-D884-4217-BE75-D652561EB9DDQ24676272-43F8C1AB-ACD3-420F-B2E2-59C0A213190CQ24679688-413746FB-C849-4686-8BF0-A86D6C120B55Q26765459-EB14165F-62B6-4793-B54C-D9B880B0011DQ26765845-A3D244E0-3CD7-46A8-ACFA-C357BBF9080BQ27641970-BE50D8D8-A41C-404F-B746-CDCDB4A3D864Q28242241-A49D96DC-6F7D-4DEF-A53E-B220DFA17E31Q28281483-C9396334-AAFA-4280-BCBD-C1385CE75363Q28347348-AA88E738-3EEA-4A60-AEF4-BF60F375EC2EQ30442878-61DAC1E0-84F2-4172-AEA6-AB535F9EE0A5Q30449840-B0619E3C-31CC-47B8-BEC2-20578AF870F3Q30452613-CE1AAF70-6E99-4851-BB07-0C080EB08AC7Q30452642-FEC76E94-0EE6-47DC-A18C-8290F2D1C6E9Q30708754-9DD69E7D-953F-41B7-BA60-719161E01A74Q30718387-9E0096AD-D550-4212-BB58-836B5E9AA8F0Q30754072-80455BB9-4BB6-4723-8485-1B4354C4C3F4Q33259097-BC20022D-FD39-44AD-B429-C953BA8FC559Q33281005-9A9E0E71-F707-442D-9E80-D873A1E56F76Q33342850-4ECCBA2F-3B25-42C1-8FE0-566A2BBD41DCQ33398779-D6F4BE14-2E90-4498-87D7-CB5883892CCAQ33522918-B1723A02-59D3-47F4-B614-34A375048ACFQ33523809-603BA8C4-F417-487C-B7BA-750D76D4FE2AQ33594882-A3A7EC63-4978-478F-8AAD-42A99C762E01Q33605976-DD5843EA-3F09-491A-809F-D950E0835650Q33696617-F9091182-8BE7-4267-BC39-A68A434B5B39Q33785691-CB444DCA-5C19-4709-91CE-0D86B678241DQ33815865-2005BEB8-4DB8-4EC9-9EE4-110BB217A39FQ33827433-30EBD656-8B70-4950-9645-BCB5414FE6FFQ33827463-3883C869-E3C8-43F2-8B44-4251BE68D456Q34069951-1F5AE4CA-C13E-440C-BE17-9EBF7FA0BBA2Q34122073-A7A478A4-50FA-4045-A123-A71228BAC357Q34450450-2BAD9621-B487-4A45-BCF7-DCCDE82099FDQ34452013-4A810FE5-014D-4A32-B292-81A372B3874CQ34496462-38A674C6-18D2-4776-ABD6-3464DE93B63FQ34498809-DA0813AA-D45A-4C3B-A500-24E458995FBBQ34592442-0D132DA5-F924-4175-A54A-6D6441A42732Q34596034-3DD28F96-8C12-4504-8B05-3DE7A255185BQ34613914-58A272C8-0A8A-4AD2-BB5A-AF110853B85EQ34624721-91F86C00-0717-46E3-95F7-C42A11F2EC8F
P2860
Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
Host resistance directed selec ...... nts. Analysis of the mechanism
@ast
Host resistance directed selec ...... nts. Analysis of the mechanism
@en
type
label
Host resistance directed selec ...... nts. Analysis of the mechanism
@ast
Host resistance directed selec ...... nts. Analysis of the mechanism
@en
prefLabel
Host resistance directed selec ...... nts. Analysis of the mechanism
@ast
Host resistance directed selec ...... nts. Analysis of the mechanism
@en
P2860
P356
P1476
Host resistance directed selec ...... nts. Analysis of the mechanism
@en
P2093
H G Ljunggren
P2860
P304
P356
10.1084/JEM.162.6.1745
P407
P4510
P577
1985-12-01T00:00:00Z